Charman Tony
Institute of Psychiatry, King's College London , London , UK.
Int J Speech Lang Pathol. 2014 Feb;16(1):15-8. doi: 10.3109/17549507.2013.859732.
Camarata's (2014) review summarizes the progress that has been made in the field of early identification and early intervention in autism spectrum disorders (ASD) over the past few decades, but also provides a salutary reminder that much still needs to be done. Whilst it is possible to prospectively identify cases of ASD using screening instruments; it is critical that those using such screens in clinical practice understand how to interpret data from published studies and consider how screening information is communicated to parents. After several decades when few randomized controlled trials of early intervention in ASD were conducted, the last decade has seen an explosion of new studies. Despite initial optimism, as more trials are published they have highlighted the limits of, and challenges to, early intervention in ASD. Given the complex nature of ASD these sobering lessons are perhaps not surprising. Rather than promote despondency, they need to inspire and inform the next decade of clinical research to move the field forward to the benefit of young children with ASD and those who care for them.
卡马拉塔(2014年)的综述总结了过去几十年间在自闭症谱系障碍(ASD)早期识别和早期干预领域所取得的进展,但也适时地提醒人们,仍有许多工作要做。虽然使用筛查工具可以前瞻性地识别ASD病例,但在临床实践中使用此类筛查的人员必须明白如何解读已发表研究的数据,并考虑如何将筛查信息传达给家长。在过去几十年里,针对ASD早期干预的随机对照试验很少,而在过去十年中,新研究激增。尽管最初人们持乐观态度,但随着更多试验的发表,它们凸显了ASD早期干预的局限性和挑战。鉴于ASD的复杂性,这些发人深省的教训或许并不令人意外。它们不应引发沮丧情绪,而应激励并为未来十年的临床研究提供信息,推动该领域向前发展,造福患有ASD的幼儿及其照料者。